ClearNote Health to Present Pancreatic Cancer Test Data at DDW 2026
ClearNote Health will present data at DDW 2026 showing its Avantect Pancreatic Cancer Test achieved 82.6% sensitivity and 97.5% specificity in patients at elevated risk.
Read More
Search Results for: diabetes testing
Policy and Payment Gaps Limit Access to Critical Diagnostic Testing
A new analysis finds that policy and payment gaps are limiting access to diagnostics, with nearly half the world lacking adequate testing and reimbursement lagging behind advances in precision therapies.
Read More
Pathologie Friesland Adopts New Digital Pathology Platform for AI Integration
The regional laboratory will use the Concentriq platform to expand diagnostic services and streamline clinical workflows across its network.
Read More
Large Study Shows Genetic Risk Results Can Be Returned to Thousands of Patients—With Caveats
A national eMERGE study found that genetic risk results can be returned at scale, with over 70% of high-risk patients receiving counseling, though disparities in access persist, according to the American Journal of Human Genetics.
Read More
Roche’s Mass Spectrometry Steroid Assays Receive FDA Moderate Complexity Designation
The Ionify steroid assay panel, which runs on the cobas i 601 analyzer, joins the previously cleared 25-Hydroxy Vitamin D total assay in Roche’s growing US mass spectrometry portfolio.
Read More